Citations

Showing 10 of 108104 citations.

Comparative analysis of outcomes in African American (AA) and white (W) patients (pts) with multiple myeloma (MM) treated with lenalidomide (LEN) or pomalidomide (POM).
Holstein, Sarah A. , Larkins, Gail, Chung, Weiyuan, Srinivasan, Shankar , Agarwal, Amit , Ailawadhi, Sikander , McCarthy, Philip L. , Lonial, Sagar

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 8050-8050

10.1200/jco.2018.36.15_suppl.8050 Get It

ILyAD (Indolent Lymphoma and Vitamin D): A phase III double blind, prospective randomized trial to evaluate the supplemental effect of vitamin D on progression-free survival in patients with low tumor-burden indolent non-Hodgkin lymphoma treated with ritux
Strawderman, Myla , Flowers, Christopher R. , Leonard, John P. , Peterson, Derick R., Friedberg, Jonathan W. , Brady, Michael, Kahl, Brad S. , Nastoupil, Loretta J. , Witzig, Thomas E.

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: TPS7587-TPS7587

10.1200/jco.2018.36.15_suppl.tps7587 Get It

Early MRD negativity to predict deepening myeloma response in relapsed/refractory multiple myeloma (RRMM) patients treated with bb2121 anti-BCMA CAR T cells.
Munshi, Nikhil C. , Liedtke, Michaela , Madduri, Deepu , Turka, Ashley, Lam, Lyh Ping, Hege, Kristen , Campbell, Timothy , Massaro, Monica, Berdeja, Jesús G. , Lin, Yi , Kochenderfer, James N. , Raje, Noopur , Jagannath, Sundar , Rosenblatt, Jacalyn , Maus, Marcela V , Petrocca, Fabio , Siegel, David S.

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 8024-8024

10.1200/jco.2018.36.15_suppl.8024 Get It

Utility and prognostic value of 18F-FDG PET/CT scan in patients with newly diagnosed multiple myeloma.
Kumar, Shaji , Kourelis, Taxiarchis , Lacy, Martha Q. , Kapoor, Prashant , Lust, John A., Hayman, Suzanne R. , Hwa, Yi L. , Kyle, Robert A. , Warsame, Rahma , Aljama, Mohammed A. , Sidiqi, M Hasib , Gertz, Morie A. , Rajkumar, S. Vincent , Gonsalves, Wilson I. , Buadi, Francis K. , Dispenzieri, Angela , Dingli, David , Leung, Nelson , Go, Ronald S.

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 8023-8023

10.1200/jco.2018.36.15_suppl.8023 Get It

Low vs high dose carfilzomib (Cfz) with dexamethasone (Dex) for relapsed/refractory multiple myeloma (RRMM): Results of SWOG S1304.
Sexton, Rachael, Lentzsch, Suzanne , Voorhees, Peter M. , Rohren, Eric , Kelly, Kevin R. , Mackler, Niklas J., Baer, David, Hoering, Antje , Durie, Brian G.M. , Ailawadhi, Sikander , Abidi, Muneer H. , Cohen, Adam D. , Heitner, Stephen B. , Orlowski, Robert Z.

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 8015-8015

10.1200/jco.2018.36.15_suppl.8015 Get It

Once-weekly vs twice-weekly carfilzomib (K) dosing plus dexamethasone (d) in patients with relapsed and refractory multiple myeloma (RRMM): Results of the randomized phase 3 study A.R.R.O.W.
Mateos, María‐Victoria , Lazzaro, Antonio, Song, Kevin , Huang, Mei , Zahlten‐Kumeli, Anita, Stewart, A. Keith, Moreau, Philippe , Berenson, James R. , Weisel, Katja C , Dimopoulos, Meletios Α.

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 8000-8000

10.1200/jco.2018.36.15_suppl.8000 Get It

Creation and validation of the “myMPN” prospective patient registry of myeloproliferative neoplasm patients.
Scherber, Robyn M. , Whyte, Lindsey, Woehrle, Michelle, Harrison, Claire , Dueck, Amylou C. , Verstovšek, Srđan , Mesa, Ruben A.

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: e19031-e19031

10.1200/jco.2018.36.15_suppl.e19031 Get It

Choosing a reduced intensity conditioning, fludarabine melphalan versus fludarabine busulfan: A meta-analysis and systematic review.
Jain, Tania , Firwana, Belal , Almader‐Douglas, Diana , Palmer, Jeanne , Jain, Tania , Sonbol, Mohamad Bassam

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: e19017-e19017

10.1200/jco.2018.36.15_suppl.e19017 Get It

Results of real-time cell-of-origin subtype identification by gene expression profiling in patients with ABC-type diffuse large B-cell lymphoma in the phase III trial of lenalidomide plus R-CHOP vs placebo plus R-CHOP (ROBUST).
Nowakowski, Grzegorz S. , Chiappella, Annalisa , Spina, Michele , Gascoyne, Randy D. , Russo, Jacqueline, Kang, Janet, Zhang, Jingshan , Xu, Yingyong, investigators, on behalf of the ROBUST study, Witzig, Thomas E. , Scott, David W. , Zhang, Lei , Vitolo, Umberto , investigators, on behalf of the ROBUST study

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 7548-7548

10.1200/jco.2018.36.15_suppl.7548 Get It